ICON Iconic Labs Plc

TIDMICON

RNS Number : 1540M

Iconic Labs PLC

12 September 2023

12 September 2023

Iconic Labs PLC

("Iconic" or the "Company")

Allotment of Shares and Conclusion of CVA

Iconic Labs PLC (LSE: ICON) today announces that 83,256 ordinary shares of GBP0.1 were allotted to the unsecured creditors (the "Unsecured Creditors") in accordance with the Creditors Voluntary Arrangement (CVA) dated 22 September 2022.

Application is being made for 83,256 new Ordinary Shares to be admitted to trading on the Main Market of the London Stock Exchange which is expected to be on or around 15 September 2023. These shares rank pari passu with the existing Ordinary Shares of the Company.

Following the issue of these shares, the Company's issued ordinary share capital shall consist of 5,003,275 Ordinary Shares. The figure of 5,003,275 represents the total voting rights in the Company and should be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance & Transparency Rules.

Brad Taylor, Chief Executive Officer of Iconic Labs, commented:

"We are pleased to announce the allotment of shares to the Unsecured Creditors satisfies the final condition to bring the CVA to a successful conclusion. Once the CVA is discharged, Iconic will be well positioned to focus on its business goals. The Board remains committed to delivering value to our shareholders and stakeholders alike. "

- Ends -

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For any further information or enquiries please contact:

 
 Iconic Labs                     Tel: +44 (0) 7462 156238 
  Brad Taylor, Chief Executive    ir@iconiclabs.co.uk 
  Officer 
 Novum Securities Limited        Tel: +44 (0) 20 7399 9400 
  David Coffman / Daniel 
  Harris 
 Yellow Jersey PR                Tel: +44 (0) 20 3004 9512 
  Sarah Hollins                   iconic@yellowjerseypr.com 
  Annabelle Wills 
  Bessie Elliot 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

STRUUSBRORUKARR

(END) Dow Jones Newswires

September 12, 2023 03:45 ET (07:45 GMT)

Grafico Azioni Iconic Labs (LSE:ICON)
Storico
Da Dic 2024 a Gen 2025

Grafico Azioni Iconic Labs (LSE:ICON)
Storico
Da Gen 2024 a Gen 2025